Treatment of invasive bladder cancer: lessons from the past and perspective for the future (Q35873130)

10 August 2017

1 reference

title

Treatment of invasive bladder cancer: lessons from the past and perspective for the future (English)

1 reference

10 August 2017

1 reference

4

Naoya Masumori

1 reference

10 August 2017

1

Taiji Tsukamoto

1 reference

10 August 2017

Hiroshi Kitamura

2

1 reference

10 August 2017

Atsushi Takahashi

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

Japanese Journal of Clinical Oncology

10 August 2017

published in

1 reference

10 August 2017

volume

34

1 reference

10 August 2017

issue

6

1 reference

10 August 2017

page(s)

295-306

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

New diagnostic strategies in the detection and staging of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

What is new in bladder cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Molecular prognostication in bladder cancer--a current perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Indications and technique of the orthotopic neobladder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

The role of systemic chemotherapy in the management of muscle-invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Efficacy of dose-intensified MEC (methotrexate, epirubicin and cisplatin) chemotherapy for advanced urothelial carcinoma: a prospective randomized trial comparing MEC and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin). Japanese Urothel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Gemcitabine and cisplatin for advanced, metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

The systemic treatment of advanced and metastatic bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Invasive, high grade transitional cell carcinoma of the bladder treated with transurethral resection. A survival analysis focusing on TUR as monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

A 4-year update on the safety of sildenafil citrate (Viagra).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYH048

21 January 2018

Identifiers

DOI

10.1093/JJCO/HYH048

1 reference

10 August 2017

1 reference